Full Text
MSR143 Matching Adjusted Indirect Comparison of Asciminib vs. Flumatinib as First-Line Treatment for Chronic Myeloid Leukemia in China

Abstract

Authors

Ying Wang Yan Hui Meng Tang Xue Gao Abhay Choubey Soni Gupta Bingcheng Liu

Back to Volume 28, Supplemental Issue 12S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×